Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Short term Debt (2018 - 2024)

Orthofix Medical's Short term Debt history spans 10 years, with the latest figure at $6.2 million for Q3 2024.

  • For the quarter ending Q3 2024, Short term Debt changed N/A year-over-year to $6.2 million, compared with a TTM value of $6.2 million through Sep 2024, changed N/A, and an annual FY2023 reading of $1.2 million, up 25.0% over the prior year.
  • Short term Debt for Q3 2024 was $6.2 million at Orthofix Medical, up from $4.7 million in the prior quarter.
  • The five-year high for Short term Debt was $17.2 million in Q4 2021, with the low at $1.0 million in Q4 2022.
  • Average Short term Debt over 5 years is $6.9 million, with a median of $4.7 million recorded in 2024.
  • Year-over-year, Short term Debt tumbled 94.19% in 2022 and then increased 25.0% in 2023.
  • Tracing OFIX's Short term Debt over 5 years: stood at $14.9 million in 2020, then rose by 15.44% to $17.2 million in 2021, then tumbled by 94.19% to $1.0 million in 2022, then increased by 25.0% to $1.2 million in 2023, then surged by 400.0% to $6.2 million in 2024.
  • Per Business Quant, the three most recent readings for OFIX's Short term Debt are $6.2 million (Q3 2024), $4.7 million (Q2 2024), and $3.1 million (Q1 2024).